** = Publications listed in SCI/SSCI/Pubmed
** Babalola, JA; Stracke, A; Loeffler, T; Schilcher, I; Sideromenos, S; Flunkert, S; Neddens, J; Lignell, A; Prokesch, M; Pazenboeck, U; Strobl, H; Tadic, J; Leitinger, G; Lass, A; Hutter-Paier, B; Hoefler, G
Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.
Mol Metab. 2024; 85:101959
Doi: 10.1016/j.molmet.2024.101959
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Babalola, JA; Stracke, A; Loeffler, T; Schilcher, I; Sideromenos, S; Flunkert, S; Neddens, J; Lignell, A; Prokesch, M; Panzenboeck, U; Strobl, H; Tadic, J; Leitinger, G; Lass, A; Hutter-Paier, B; Hoefler, G
Corrigendum to "Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice" [MOLMET 85 (2024) 1-16].
Mol Metab. 2024; 86:101972
Doi: 10.1016/j.molmet.2024.101972
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Babalola, JA; Lang, MGLA; George, M; Stracke, A; Tam-Amersdorfer, C; Itxaso, I; Lucija, D; Tadic, J; Schilcher, I; Loeffler, T; Flunkert, S; Prokesch, M; Leitinger, G; Lass, A; Hutter-Paier, B; Panzenboeck, U; Hoefler, G
Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation
BRAIN RES. 2023; 1819: 148518
Doi: 10.1016/j.brainres.2023.148518
Web of Science
PubMed
FullText
FullText_MUG
** Hinteregger, B; Loeffler, T; Flunkert, S; Neddens, J; Bayer, TA; Madl, T; Hutter-Paier, B
Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.
J ALZHEIMERS DIS. 2021; 80(3): 1151-1168.
Doi: 10.3233/JAD-201204
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hinteregger, B; Loeffler, T; Flunkert, S; Neddens, J; Birner-Gruenberger, R; Bayer, TA; Madl, T; Hutter-Paier, B
Transgene integration causes RARB downregulation in homozygous Tg4-42 mice.
Sci Rep. 2020; 10(1): 6377-6377.
Doi: 10.1038/s41598-020-63512-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Löffler, T; Schweinzer, C; Flunkert, S; Sántha, M; Windisch, M; Steyrer, E; Hutter-Paier, B
Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice.
Mol Cell Neurosci. 2016; 74(2):34-41
Doi: 10.1016/j.mcn.2016.03.004
Web of Science
PubMed
FullText
FullText_MUG
** Löffler, T; Flunkert, S; Havas, D; Schweinzer, C; Uger, M; Windisch, M; Steyrer, E; Hutter-Paier, B
Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease.
J Neuroinflammation. 2014; 11(7):84-84
Doi: 10.1186/1742-2094-11-84
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Flunkert, S; Hierzer, M; Löffler, T; Rabl, R; Neddens, J; Duller, S; Schofield, EL; Ward, MA; Posch, M; Jungwirth, H; Windisch, M; Hutter-Paier, B
Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
Neurodegener Dis. 2013; 11(4):194-205
Doi: 10.1159/000338152
Web of Science
PubMed
FullText
FullText_MUG
** Löffler, T; Flunkert, S; Havas, D; Sántha, M; Hutter-Paier, B; Steyrer, E; Windisch, M
Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice.
Neurobiol Aging. 2013; 34(10):2379-2388
Doi: 10.1016/j.neurobiolaging.2013.04.008
Web of Science
PubMed
FullText
FullText_MUG
** Löffler, T; Flunkert, S; Taub, N; Schofield, EL; Ward, MA; Windisch, M; Hutter-Paier, B
Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.
J Mol Neurosci. 2012; 47(1): 192-203.
Doi: 10.1007/s12031-012-9716-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG